RxDoctor Payments Data

John Dorris, MD

Orthopaedic Surgery · Athens, GANPI 1104807429

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $64,596 of the $68,124 with a category attached, or 94.8%. Tracpatch Health, Inc accounts for 94.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $34,758 and has fallen 99.6% since, to $123 in 2025. Among orthopaedic surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$68,124in general payments, 2019–2025

Across 45 payments — averaging $1513.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tracpatch Health, Inc$65K
  • Shalby Advanced Technologies, Inc.$2K
  • Stryker$548
  • Osteoremedies, LLC$417
  • Encore Medical, LP$167
  • Arthrosurface Incorporated$82
  • plus $347 from 8 others

What the payments were for

  • Royalty or licence$450%
  • Consulting fees$1,5002%
  • Food & beverage$1,9833%
  • Ownership interest$64,59695%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$68,124 in reported general payments places this provider in the 90th percentile of 654 orthopaedic surgery providers in Georgia.

See all orthopaedic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$283,586
Medicare patients
507
Services billed
4,684

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl254$1,421
Celecoxib36$440
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen52$423
Meloxicam218$414
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen48$393
Tramadol Hcl128$329
Prednisone55$298
Diclofenac Sodium27$177
Ondansetron Hcl28$141
Cephalexin23$140
Famotidine17$136
Gabapentin31$132
Hydromorphone Hcl24$113
Clindamycin Hcl44$101
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$52

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Athens

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →